Neoadjuvant androgen withdrawal prior to external radiotherapy for locally advanced adenocarcinoma of the prostate

International Journal of Urology

Volumn 9, Issue 6, 2002, Pages 322-328

  Hara, Isao ^a   Miyake, Hideaki ^a   Yamada, Yuji ^b   Takechi, Yoshizumi ^b   Hara, Shoji ^a   Gotoh, Akinobu ^a   Fujisawa, Masato ^a   Okada, Hiroshi ^a   Arakawa, Soichi ^a   Soejima, Toshinori ^a   Sugimura, Kazuro ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

LNCaP tumor model; Locally advanced prostate cancer; Neoadjuvant androgen ablation; Radiotherapy

Indexed keywords

ANDROGEN; GONADORELIN; GOSERELIN; LEUPRORELIN; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; TREATMENT OUTCOME; TUMOR GROWTH; ADENOCARCINOMA; ADJUVANT THERAPY; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CLINICAL TRIAL; DISEASE MODEL; IN VITRO STUDY; MIDDLE AGED; ORCHIECTOMY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; ANIMAL; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE MODELS, ANIMAL; GOSERELIN; HUMAN; IN VITRO; LEUPROLIDE; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGE; NEOADJUVANT THERAPY; ORCHIECTOMY; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; ANIMALS; HUMANS; MIDDLE AGED;

EID: 0036069275     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2002.00470_1.x     Document Type: Article

References (22)

1. Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
2. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the radiation therapy oncology group
3. Patterns of care studies: Dose response observations for local control of adenocarcinoma of the prostate
4. Control of prostate cancer with radiotherapy: Long-term results
5. The treatment of prostate cancer by conventional radiation therapy. An analysis of long-term outcome
6. Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer
7. Radical radiation therapy in the management of prostatic adenocarcinoma: The initial prostate-specific antigen value as a predictor of treatment outcome
8. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: Interim report of a phase I dose-escalation study
9. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
10. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: A reduction in acute morbidity
11. Prognosis and prostate volume changes during endocrine management of prostate carcinoma: A longitudinal study
12. The effect of androgen deprivation on an androgen sensitive tumor: An in vivo and in vitro study
13. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation in localized prostate cancer
14. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides
15. Neoadjuvant hormone therapy: The Canadian trials
16. The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma
17. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis
18. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: Correlation with original histologic grade and current PSA levels
19. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer
20. External beam radiation monotherapy for prostate cancer
21. Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting antiapoptotic genes up-regulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity
22. Optimal timing and dosage of chemotherapy as a combined treatment with androgen withdrawal in the human prostate LNCaP tumor model